A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes

OBJECTIVE: To evaluate whether LY2605541 results in lower fasting blood glucose (FBG) versus insulin glargine (GL). RESEARCH DESIGN AND METHODS: This 12-week, randomized, open-label, Phase 2 study enrolled patients with type 2 diabetes (hemoglobin A(1c) [A1C] ≤ 10.5%), taking metformin and/or sulfon...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bergenstal, Richard M., Rosenstock, Julio, Arakaki, Richard F., Prince, Melvin J., Qu, Yongming, Sinha, Vikram P., Howey, Daniel C., Jacober, Scott J.
Format: Artigo
Langue:Inglês
Publié: American Diabetes Association 2012
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3476888/
https://ncbi.nlm.nih.gov/pubmed/22787177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-0060
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires